Comparative assessment of three different second-line regimens in chemotherapy resistant / refractory small-cell lung cancer

dc.date.accessioned	2023-03-06T07:31:40Z
dc.date.available	2023-03-06T07:31:40Z
dc.date.issued	2021
dc.identifier.citation	J BUON. 2021 Jan-Feb;26(1):79-86.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/99874
dc.title	Comparative assessment of three different second-line regimens in chemotherapy resistant / refractory small-cell lung cancer
dc.relation.journal	J BUON
dc.contributor.author	Hacibekiroglu I
dc.contributor.author	Hacibekiroglu I
dc.contributor.author	Ozkul O
dc.contributor.author	Cakir E
dc.contributor.author	Kostek O
dc.contributor.author	Karatas F
dc.contributor.author	Esenkaya A
dc.contributor.author	Demirci A